UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.987-994

2012

Volltextzugriff (PDF)

A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology

British journal of cancer, 2013-10, Vol.109 (9), p.2295-2300

2013

Volltextzugriff (PDF)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma

British journal of cancer, 2013-06, Vol.108 (12), p.2470-2477

2013

Volltextzugriff (PDF)

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

British journal of cancer, 2014-04, Vol.110 (8), p.1923-1929

2014

Volltextzugriff (PDF)

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies

British journal of cancer, 2011-02, Vol.104 (3), p.399-406

2011

Volltextzugriff (PDF)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

British journal of cancer, 2014-03, Vol.110 (5), p.1125-1132

2014

Volltextzugriff (PDF)

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

British journal of cancer, 2000-02, Vol.82 (4), p.812-817

2000

Volltextzugriff (PDF)

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

British journal of cancer, 2011-07, Vol.105 (3), p.346-352

2011

Volltextzugriff (PDF)

Revised UK guidelines for the management of cutaneous melanoma 2010

Journal of plastic, reconstructive & aesthetic surgery, 2010-09, Vol.63 (9), p.1401-1419

2010

Volltextzugriff (PDF)

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3312-3322

2001

Volltextzugriff (PDF)

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens

British journal of cancer, 2007-12, Vol.97 (12), p.1618-1624

2007

Volltextzugriff (PDF)

U.K. guidelines for the management of cutaneous melanoma

British journal of dermatology (1951), 2002-01, Vol.146 (1), p.7-17

2002

Volltextzugriff (PDF)

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

British journal of cancer, 2011-07, Vol.105 (3), p.353-359

2011

Volltextzugriff (PDF)

A phase I II trial of sorafenib and infliximab in advanced renal cell carcinoma

British journal of cancer, 2010-10, Vol.103 (8), p.1149-1153

2010

Volltextzugriff (PDF)

Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3153-3160

2014

Volltextzugriff (PDF)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

British journal of cancer, 2015-06, Vol.113 (1), p.12-19

2015

Volltextzugriff (PDF)

Mucinous ovarian cancer

International journal of gynecological cancer, 2008-03, Vol.18 (2), p.209-214

2008

Volltextzugriff (PDF)

Temsirolimus in the treatment of advanced renal cell carcinoma

Annals of oncology, 2007-07, Vol.18 (suppl-9), p.ix87-ix88

Gore, ME

2007

Volltextzugriff (PDF)

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

European journal of cancer (1990), 2012-05, Vol.48 (7), p.1038-1047

2012

Volltextzugriff (PDF)

Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer

European journal of obstetrics & gynecology and reproductive biology, 2008-05, Vol.138 (1), p.71-75

2008

Volltextzugriff (PDF)

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

Journal of clinical oncology, 2023-10, Vol.41 (28), p.4453-4454

2023

Volltextzugriff (PDF)

Second primary melanomas on treatment with vemurafenib: reply from the authors

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.888-889

2013

Volltextzugriff (PDF)

Significance of tumour calcification in ovarian carcinoma

British journal of radiology, 2009-08, Vol.82 (980), p.640-644

2009

Volltextzugriff (PDF)

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

British journal of cancer, 2004-08, Vol.91 (5), p.829-833

2004

Volltextzugriff (PDF)

The treatment of advanced renal cell cancer with high-dose oral thalidomide

British journal of cancer, 2001-09, Vol.85 (7), p.953-958

2001

Volltextzugriff (PDF)

1 – 25 von 1.748

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.567)
Mit Volltextzugriff
(1.424)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.080)
Life Sciences & Biomedicine
(979)
Humans
(873)
Female
(573)
Male
(494)
Biological And Medical Sciences
(492)
Medical Sciences
(448)
Middle Aged
(384)
Adult
(363)
Aged
(311)
Oncology
(258)
Pharmacology. Drug Treatments
(166)
Animals
(143)
Treatment Outcome
(127)
Adolescent
(111)
General & Internal Medicine
(105)
Antineoplastic Agents
(98)
Tumors
(92)
Aged, 80 And Over
(90)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(89)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

Revised UK guidelines for the management of cutaneous melanoma 2010

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens

U.K. guidelines for the management of cutaneous melanoma

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

A phase I II trial of sorafenib and infliximab in advanced renal cell carcinoma

Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

Mucinous ovarian cancer

Temsirolimus in the treatment of advanced renal cell carcinoma

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

Second primary melanomas on treatment with vemurafenib: reply from the authors

Significance of tumour calcification in ovarian carcinoma

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

The treatment of advanced renal cell cancer with high-dose oral thalidomide

Suchergebnisse filtern